Cost of two different therapies for end-stage renal disease in northwest China

Journal of Medical Colleges of PLA

Volumn 27, Issue 2, 2012, Pages 80-86

  Xiaoming, Pan ^a   Heli, Xiang ^a,b   Chenguang, Ding ^a   Hua, Liu ^a   Guozhen, Chen ^b   Tianci, Mao ^b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cost effectiveness analysis; Economics; Financial analysis; Hemodialysis; Renal transplantation

Indexed keywords

DILTIAZEM;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CHINA; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEALTH CARE COST; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 84861766813     PISSN: 10001948     EISSN: 18764797     Source Type: Journal    
DOI: 10.1016/S1000-1948(12)60009-4     Document Type: Article

References (14)

1. Prodjosudjadi W Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia. Ethn Dis 2006, 16(2 Suppl 2):14-16. S2.
2. Zelmer JL The economic burden of end-stage renal disease in Canada. Kidney Int 2007, 72(9):1122-1129.
3. Winkelmayer WC, Weinstein MC, Mittleman MA, et al. Health economic evaluations: The special case of endstage renal disease treatment. Med Decis Making 2002, 22(5):417-430.
4. Howard K, Salkeld G, White S, et al. The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology (Carlton) 2009, 14(1):123-132.
5. Nakajima I, Akamatsu M, Tojimbara T, et al. Economic study of renal transplantation: a single-center analysis in Japan. Transplant Proc 2001, 33(1-2):1891-1892.
6. Matas AJ, Schnitzler M Payment for living donor (vendor) kidneys: a cost-effectiveness analysis. Am J Transplant 2004, 4(2):216-221.
7. Kishore RR Human organs, scarcities, and sale: morality revisited. J Med Ethics 2005, 31(6):362-365.
8. Roels L, Kalo Z, Boesebeck D, et al. Cost-benefit approach in evaluating investment into donor action: the German case. Transpl Int 2003, 16(5):321-326.
9. Modi GK, Jha V The incidence of end-stage renal disease in India: a population-based study. Kidney Int 2006, 70(12):2131-2133.
10. Erek E, Sever MS, Akoglu E, et al. Cost of renal replacement therapy in Turkey. Nephrology (Carlton) 2004, 9(1):33-38.
11. Nourbala MH, Einollahi B, Kardavani B, et al. The cost of kidney transplantation in Iran. Transplant Proc 2007, 39(4):927-929.
12. Englesbe MJ, Dimick JB, Fan Z, et al. Case mix, quality and high-cost kidney transplant patients. Am J Transplant 2009, 9(5):1108-1114.
13. Perović S, Janković S Renal transplantation vs hemodialysis: cost-effectiveness analysis. Vojnosanit Pregl 2009, 66(8):639-644.
14. Englesbe MJ, Ads Y, Cohn JA, et al. The effects of donor and recipient practices on transplant center finances. Am J Transplant 2008, 8(3):586-592. (Editor Lu Renmin).